These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8220405)

  • 21. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Random assignment of available cases: bootstrap standard errors and confidence intervals.
    Lunneborg CE
    Psychol Methods; 2001 Dec; 6(4):402-12. PubMed ID: 11778680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical versus statistical significance: interpreting P values and confidence intervals related to measures of association to guide decision making.
    Ferrill MJ; Brown DA; Kyle JA
    J Pharm Pract; 2010 Aug; 23(4):344-51. PubMed ID: 21507834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical evidence of an association between internal validity and effect size in randomized controlled trials of low-back pain.
    van Tulder MW; Suttorp M; Morton S; Bouter LM; Shekelle P
    Spine (Phila Pa 1976); 2009 Jul; 34(16):1685-92. PubMed ID: 19770609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missing inaction: preventing missing outcome data in randomized clinical trials.
    Wittes J
    J Biopharm Stat; 2009 Nov; 19(6):957-68. PubMed ID: 20183458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why confidence intervals are useful tools in clinical therapeutics.
    Simon R
    J Biopharm Stat; 1993 Sep; 3(2):243-8. PubMed ID: 8220406
    [No Abstract]   [Full Text] [Related]  

  • 29. If it hasn't failed, does it work? On 'the worst we can expect' from observational trial results, with reference to airway management devices.
    Pandit JJ
    Anaesthesia; 2012 Jun; 67(6):578-83. PubMed ID: 22563955
    [No Abstract]   [Full Text] [Related]  

  • 30. Interpreting and reporting clinical trials with results of borderline significance.
    Hackshaw A; Kirkwood A
    BMJ; 2011 Jul; 343():d3340. PubMed ID: 21727163
    [No Abstract]   [Full Text] [Related]  

  • 31. [How may practitioners interpret the results of clinical trials?].
    Azorin JM; Adida M; Blin O; Simon N; Fakra E; Cermolacce M; Bottai T; Pringuey D; Micoulaud-Franchi JA; Belzeaux R; Kaladjian A
    Encephale; 2016 Dec; 42(6S):S26-S29. PubMed ID: 28236989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confidence intervals and p-values in clinical decision making.
    Akobeng AK
    Acta Paediatr; 2008 Aug; 97(8):1004-7. PubMed ID: 18462462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical significance versus clinical relevance. Part II. The use and interpretation of confidence intervals.
    Luus HG; Müller FO; Meyer BH
    S Afr Med J; 1989 Dec; 76(11):626-9. PubMed ID: 2595492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing for qualitative interaction using ratios of treatment differences.
    Kitsche A; Hothorn LA
    Stat Med; 2014 Apr; 33(9):1477-89. PubMed ID: 24302387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A unified method for monitoring and analysing controlled trials.
    Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials and p-values, beware of the extremes.
    Cleophas TJ
    Clin Chem Lab Med; 2004 Mar; 42(3):300-4. PubMed ID: 15080563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What does characterize a good drug clinical trial?].
    Skovlund E
    Tidsskr Nor Laegeforen; 2001 Jan; 121(3):336-8. PubMed ID: 11242879
    [No Abstract]   [Full Text] [Related]  

  • 38. [How to deal with equivocal subjects in statistical analysis of randomized controlled trials].
    Hamajima N; Ohno R
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1537-42. PubMed ID: 2230438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous confidence intervals on multivariate non-inferiority.
    Hasler M; Hothorn LA
    Stat Med; 2013 May; 32(10):1720-9. PubMed ID: 22996204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confidence intervals illuminate absence of evidence.
    Altman D; Bland JM
    BMJ; 2004 Apr; 328(7446):1016-7. PubMed ID: 15105337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.